Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Apr-24 8:00 PM View:  | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 03-Apr-24 | Private Sale (Planned) | 15,630 | $6.17 | $96,421.50 | (32%) 49.55K to 33.92K | |
| 13-Dec-23 4:33 PM View: | Ra Capital Management, LLC Director 10% Owner | Wave Life Sciences Ltd. (WVE) | 11-Dec-23 | Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 5% 18.2M to 19.2M | |
| 30-Jan-24 4:39 PM View: | Glaxosmithkline Plc 10% Owner | Wave Life Sciences Ltd. (WVE) | 07-Dec-23 | Purchase | 3,300,000 | $5.00 | $16,500,000.00 | 31% 10.68M to 13.98M | |
| 23-Aug-23 9:15 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 23-Aug-23 | Private Sale (Planned) | 37,062 | $4.75 | $176,119.00 | (45%) 83.18K to 46.12K | |
| 17-Feb-23 8:10 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 16-Feb-23 | Private Sale | 29,400 | $4.04 | $118,776.00 | (7%) 436.82K to 407.43K | |
| 17-Feb-23 8:15 PM View: | Vargeese Chandra See Remarks | Wave Life Sciences Ltd. (WVE) | 16-Feb-23 | Private Sale | 10,249 | $4.03 | $41,303.50 | (9%) 116.87K to 106.62K | |
| 17-Feb-23 8:05 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 16-Feb-23 | Private Sale | 10,258 | $4.03 | $41,339.70 | (11%) 89.97K to 79.71K | |
| 17-Feb-23 8:00 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 16-Feb-23 | Private Sale | 9,729 | $4.04 | $39,305.20 | (11%) 89.48K to 79.75K | |
| 21-Jun-22 4:33 PM View: | Ra Capital Management, LLC Director 10% Owner | Wave Life Sciences Ltd. (WVE) | 16-Jun-22 | Private Purchase | 9,480,050 | $2.15 | $20,382,100.00 | 123% 7.72M to 17.2M | |
| 06-May-22 7:05 PM View: | Panzara Michael A. See Remarks | Wave Life Sciences Ltd. (WVE) | 05-May-22 | Sale (Planned) | 16,714 | $1.72 | $28,748.10 | (13%) 125.82K to 109.1K | |
| 06-May-22 7:15 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 05-May-22 | Sale (Planned) | 33,501 | $1.72 | $57,621.70 | (7%) 470.33K to 436.82K | |
| 06-May-22 7:20 PM View: | Vargeese Chandra See Remarks | Wave Life Sciences Ltd. (WVE) | 05-May-22 | Sale (Planned) | 16,714 | $1.72 | $28,748.10 | (13%) 127.81K to 111.09K | |
| 06-May-22 7:00 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 05-May-22 | Sale (Planned) | 10,867 | $1.72 | $18,691.20 | (11%) 100.84K to 89.97K | |
| 06-May-22 7:10 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 05-May-22 | Sale (Planned) | 5,021 | $1.72 | $8,636.12 | (6%) 89.59K to 84.57K | |
| 06-May-22 7:05 PM View: | Panzara Michael A. See Remarks | Wave Life Sciences Ltd. (WVE) | 04-May-22 | Grant | 50,000 | -- | -- | 66% 75.82K to 125.82K | |
| 06-May-22 7:15 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 04-May-22 | Grant | 92,500 | -- | -- | 24% 377.83K to 470.33K | |
| 06-May-22 7:20 PM View: | Vargeese Chandra See Remarks | Wave Life Sciences Ltd. (WVE) | 04-May-22 | Grant | 50,000 | -- | -- | 64% 77.81K to 127.81K | |
| 06-May-22 7:00 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 04-May-22 | Grant | 32,500 | -- | -- | 48% 68.34K to 100.84K | |
| 06-May-22 7:10 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 04-May-22 | Grant | 15,000 | -- | -- | 20% 74.59K to 89.59K | |
| 18-Feb-22 6:00 PM View: | Panzara Michael A. See Remarks | Wave Life Sciences Ltd. (WVE) | 16-Feb-22 | Sale | 10,603 | $2.31 | $24,492.90 | (12%) 86.42K to 75.82K | |
| 18-Feb-22 6:05 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 16-Feb-22 | Sale | 33,150 | $2.32 | $76,908.00 | (8%) 410.98K to 377.83K | |
| 18-Feb-22 6:15 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 16-Feb-22 | Sale | 10,123 | $2.31 | $23,384.10 | (13%) 78.46K to 68.34K | |
| 18-Feb-22 6:20 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 16-Feb-22 | Sale | 9,204 | $2.31 | $21,261.20 | (11%) 83.79K to 74.59K | |
| 18-Feb-22 6:10 PM View: | Vargeese Chandra Chief Technology Officer | Wave Life Sciences Ltd. (WVE) | 16-Feb-22 | Sale | 10,603 | $2.32 | $24,599.00 | (12%) 88.41K to 77.81K | |
| 05-Apr-21 4:33 PM View: | Ra Capital Management, LLC Director 10% Owner | Wave Life Sciences Ltd. (WVE) | 01-Apr-21 | Acquisition (other) | 970,025 | $5.61 | $5,441,840.00 | 14% 6.81M to 7.78M | |
| 24-Mar-21 7:45 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 24-Mar-21 | Option Exercise | 10,930 | $2.48 | $27,106.40 | 16% 69.86K to 80.79K | |
| 18-Feb-21 7:18 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 16-Feb-21 | Market Sale (Planned) | 11,205 | $10.57 | $118,437.00 | (3%) 422.18K to 410.98K | |
| 18-Feb-21 7:14 PM View: | Vargeese Chandra Chief Technology Officer | Wave Life Sciences Ltd. (WVE) | 16-Feb-21 | Market Sale (Planned) | 3,145 | $10.57 | $33,242.60 | (4%) 88.56K to 85.41K | |
| 18-Feb-21 7:16 PM View: | Panzara Michael A. See Remarks | Wave Life Sciences Ltd. (WVE) | 16-Feb-21 | Market Sale (Planned) | 2,929 | $10.57 | $30,959.50 | (3%) 89.35K to 86.42K | |
| 18-Feb-21 7:26 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 16-Feb-21 | Market Sale (Planned) | 2,698 | $10.57 | $28,517.90 | (3%) 81.16K to 78.46K | |
| 18-Feb-21 7:09 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 16-Feb-21 | Market Sale (Planned) | 1,722 | $10.57 | $18,201.50 | (2%) 71.58K to 69.86K | |
| 18-Feb-21 7:09 PM View: | Moran Kyle Chief Financial Officer | Wave Life Sciences Ltd. (WVE) | 01-Feb-21 | Grant | 50,000 | -- | -- | 232% 21.58K to 71.58K | |
| 18-Feb-21 7:14 PM View: | Vargeese Chandra Chief Technology Officer | Wave Life Sciences Ltd. (WVE) | 01-Feb-21 | Grant | 50,000 | -- | -- | 130% 38.56K to 88.56K | |
| 18-Feb-21 7:16 PM View: | Panzara Michael A. See Remarks | Wave Life Sciences Ltd. (WVE) | 01-Feb-21 | Grant | 50,000 | -- | -- | 127% 39.35K to 89.35K | |
| 18-Feb-21 7:26 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 01-Feb-21 | Grant | 50,000 | -- | -- | 160% 31.16K to 81.16K | |
| 18-Feb-21 7:18 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 01-Feb-21 | Grant | 150,000 | -- | -- | 55% 272.18K to 422.18K | |
| 17-Sep-20 9:10 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 15-Sep-20 | Option Exercise | 100,000 | $2.48 | $248,000.00 | 37% 272.18K to 372.18K | |
| 17-Sep-20 9:10 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 15-Sep-20 | Market Option Sale (Planned) | 100,000 | $15.00 | $1,500,000.00 | (27%) 372.18K to 272.18K | 41% |
| 27-Aug-20 6:44 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 25-Aug-20 | Option Exercise | 25,000 | $2.48 | $62,000.00 | 9% 272.18K to 297.18K | |
| 27-Aug-20 6:44 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 25-Aug-20 | Market Option Sale (Planned) | 25,000 | $12.00 | $300,000.00 | (8%) 297.18K to 272.18K | 26% |
| 02-Jul-20 8:56 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 02-Jul-20 | Market Sale (Planned) | 47,577 | $10.30 | $490,118.00 | (15%) 319.76K to 272.18K | 14% |
| 02-Jul-20 8:56 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 02-Jul-20 | Market Option Sale (Planned) | 100,000 | $10.30 | $1,030,160.00 | (24%) 419.76K to 319.76K | 14% |
| 02-Jul-20 8:56 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 02-Jul-20 | Option Exercise | 100,000 | $2.48 | $248,000.00 | 31% 319.76K to 419.76K | |
| 20-Feb-20 6:26 PM View: | Panzara Michael A. Chief Medical Officer | Wave Life Sciences Ltd. (WVE) | 18-Feb-20 | Market Sale (Planned) | 2,981 | $7.85 | $23,400.80 | (7%) 42.33K to 39.35K | (13%) |
| 20-Feb-20 6:23 PM View: | Bolno Paul President and CEO Director | Wave Life Sciences Ltd. (WVE) | 18-Feb-20 | Market Sale (Planned) | 11,451 | $7.85 | $89,890.40 | (3%) 331.21K to 319.76K | (13%) |
| 20-Feb-20 6:21 PM View: | Francis Chris See Remarks | Wave Life Sciences Ltd. (WVE) | 18-Feb-20 | Market Sale (Planned) | 2,708 | $7.85 | $21,257.80 | (8%) 33.87K to 31.16K | (13%) |
| 20-Feb-20 6:18 PM View: | Vargeese Chandra Senior VP, Drug Discovery | Wave Life Sciences Ltd. (WVE) | 18-Feb-20 | Market Sale (Planned) | 3,188 | $7.85 | $25,025.80 | (8%) 40.24K to 37.06K | (13%) |
| 05-Feb-20 6:16 PM View: | Gaiero David G Interim CFO | Wave Life Sciences Ltd. (WVE) | 03-Feb-20 | Market Sale (Planned) | 651 | $7.00 | $4,557.00 | (9%) 7.04K to 6.39K | (27%) |
| 05-Dec-19 6:08 PM View: | Vargeese Chandra Senior VP, Drug Discovery | Wave Life Sciences Ltd. (WVE) | 03-Dec-19 | Option Exercise | 6,000 | $2.48 | $14,880.00 | 15% 40.24K to 46.24K | |
| 05-Dec-19 6:08 PM View: | Vargeese Chandra Senior VP, Drug Discovery | Wave Life Sciences Ltd. (WVE) | 03-Dec-19 | Market Option Sale (Planned) | 6,000 | $35.00 | $210,000.00 | (13%) 46.24K to 40.24K | 75% |
